서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Author

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 16 of 16

Issue DateTitle / Author(s) / CitationFileAltmetrics
2012-03
A Case Report of Breast Cancer with Extensive Pulmonary Lymphovascular Tumor Emboli
DOI
2016-03
Phase I study of random healthy donor-derived allogeneic natural killer cell therapy in patients with malignant lymphoma or advanced solid tumors
DOI
2016-03
Prognostic implication of serum hepatocyte growth factor in stage II/III breast cancer patients who received neoadjuvant chemotherapy
DOI
2016-07
Prognostic impact of AJCC response criteria for neoadjuvant chemotherapy in stage II/III breast cancer patients: breast cancer subtype analyses
DOI
2016-07
Loss of ataxia-telangiectasia-mutated protein expression correlates with poor prognosis but benefits from anthracycline-containing adjuvant chemotherapy in breast cancer
DOI
2017-01
Anti-tumor activity of the ATR inhibitor AZD6738 in HER2 positive breast cancer cells
DOI
2017-04
Efficacy of Letrozole as First-Line Treatment of Postmenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer in Korea
DOI
2017-04
AZD6738, A Novel Oral Inhibitor of ATR, Induces Synthetic Lethality with ATM Deficiency in Gastric Cancer Cells
DOI
2017-07
Antitumor Effect of KX-01 through Inhibiting Src Family Kinases and Mitosis
DOI
2017-07
CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy
DOI
2018-12
Androgen receptor inhibitor enhances the antitumor effect of PARP inhibitor in breast cancer cells by modulating DNA damage response
DOI
2019-01
Epidermal growth factor receptor gene amplification predicts worse outcome in patients with surgically resected nonadenocarcinoma lung cancer

Chang, Hyun; Yang, Yaewon; Lee, Jong-Seok; Jheon, Sang-Hoon; Kim, Yu Jung; Chung, Jin-Haeng

Clinical Lung Cancer, Vol.20 No.1, pp.7-12.e1

DOI
2019-05
Prognostic effects of abnormal DNA damage response protein expression in breast cancer
DOI
2020-04
Prognostic role of androgen receptor expression in surgically resected early breast cancer patients
DOI
2020-12
Clinical implications of HER2 mRNA expression and intrinsic subtype in refractory HER2-positive metastatic breast cancer treated with pan-HER inhibitor, poziotinib
DOI
2021-01
Genomic profile of metastatic breast cancer patient-derived xenografts established using percutaneous biopsy
DOI
1